Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

被引：0
|
作者：
Pizzutilo, P. [1 ]
Catino, A. [1 ]
Montrone, M. [1 ]
Longo, V. [1 ]
Ricci, D. [1 ]
Pesola, F. [1 ]
Marech, I. [1 ]
Mastrandrea, A. [1 ]
Petrillo, P. [1 ]
Zacheo, A. [1 ]
Varesano, N. [1 ]
Lamorgese, V. [1 ]
Bafunno, D. [1 ]
Galetta, D. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Thorac Oncol, Thorac Oncol Unit, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; Gender-related outcome; advanced lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.14
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [1] Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting
    Skribek, Marcus
    Rounis, Konstantinos
    Makrakis, Dimitrios
    Agelaki, Sofia
    Mavroudis, Dimitris
    De Petris, Luigi
    Ekman, Simon
    Tsakonas, Georgios
    CANCERS, 2020, 12 (12) : 1 - 13
  • [2] Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis
    Paderi, Agnese
    Gambale, Elisabetta
    Botteri, Cristina
    Giorgione, Roberta
    Lavacchi, Daniele
    Brugia, Marco
    Mazzoni, Francesca
    Giommoni, Elisa
    Bormioli, Susanna
    Amedei, Amedeo
    Pillozzi, Serena
    Matucci Cerinic, Marco
    Antonuzzo, Lorenzo
    MOLECULES, 2021, 26 (19):
  • [3] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center
    Ng, Kennedy Yao Yi
    Wong, Lawrence Wen Jun
    Ang, Andrea Jing Shi
    Tan, Sze Huey
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E249 - E261
  • [4] Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
    Kobayashi, Hiroki
    Furubayashi, Nobuki
    Morihara, Kaede
    Nakamura, Motonobu
    Negishi, Takahito
    ONCOLOGY, 2025,
  • [5] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Tsai, Hong-Ming
    Han, Meng-Zhi
    Lin, Yih-Jyh
    Chang, Ting-Tsung
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chen, Po-Jun
    Kang, Jui-Wen
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Kuo, Hsin-Yu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1929 - 1937
  • [6] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Hong-Ming Tsai
    Meng-Zhi Han
    Yih-Jyh Lin
    Ting-Tsung Chang
    Chiung-Yu Chen
    Pin-Nan Cheng
    Chiao-Hsiung Chuang
    I-Chin Wu
    Po-Jun Chen
    Jui-Wen Kang
    Yen-Cheng Chiu
    Hung-Chih Chiu
    Shih-Chieh Chien
    Hsin-Yu Kuo
    Cancer Immunology, Immunotherapy, 2021, 70 : 1929 - 1937
  • [7] Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
    Zheng, Yichen
    Guo, Jiamin
    Ren, Tonghui
    Ma, Ji
    Cao, Dan
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [8] Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
    Mouritzen, Mette T.
    Junker, Karen F.
    Carus, Andreas
    Ladekarl, Morten
    Meldgaard, Peter
    Nielsen, Anders W. M.
    Livbjerg, Anna
    Larsen, Jacob W.
    Skuladottir, Halla
    Kristiansen, Charlotte
    Wedervang, Kim
    Schytte, Tine
    Hansen, Karin H.
    Ostby, Anne-Cathrine
    Frank, Malene S.
    Lauritsen, Jakob
    Sorensen, Jens B.
    Langer, Seppo W.
    Persson, Gitte F.
    Andersen, Jon L.
    Homann, Pernille H.
    Kristensen, Emilie B.
    Drivsholm, Lars B.
    Bogsted, Martin
    Christensen, Heidi S.
    Pohl, Mette
    Bjornhart, Birgitte
    ACTA ONCOLOGICA, 2022, 61 (04) : 409 - 416
  • [9] Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
    She, Jianqing
    Liu, Hui
    Wu, Haoyu
    Tuerhongjiang, Gulinigaer
    Zheng, Tao
    Bai, Ling
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [10] Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
    Toribio-Garcia, Irene
    Olivares-Hernandez, Alejandro
    Miramontes-Gonzalez, Jose Pablo
    Dominguez, Luis Posado
    Garcia, Ana Martin
    Bachiller, Rocio Eiros
    Figuero-Perez, Luis
    Martinez, Maria Garijo
    Ruiz, Jonnathan Roldan
    Hernandez, Lorena Bellido
    Fonseca-Sanchez, Emilio
    Sanchez, Pedro Luis
    del Barco-Morillo, Edel
    CANCERS, 2023, 15 (17)
12345